isradipine has been researched along with Decerebrate Posturing in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mir, AK | 1 |
| Berthold, H | 1 |
| Scholtysik, GE | 1 |
| Fozard, JR | 1 |
| Jie, K | 1 |
| van Brummelen, P | 1 |
| Timmermans, PB | 1 |
| Thoolen, MJ | 1 |
| van Zwieten, PA | 1 |
2 other studies available for isradipine and Decerebrate Posturing
| Article | Year |
|---|---|
Cardiovascular effects of endothelin 1 in pithed spontaneously hypertensive rats: evaluation of its mechanism(s) of action.
Topics: Angiotensin II; Animals; Coronary Circulation; Decerebrate State; Dose-Response Relationship, Drug; | 1989 |
Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Calcium Channel Blockers; Catecholamin | 1985 |